Tag: Peripheral Artery Disease
Smoking Has Long-Term Impact on Peripheral Artery Disease Risk
Risk for peripheral artery disease remains 30 years after smoking cessation
Risk for Leg Amputation Higher With Microvascular Disease
Risk higher regardless of microvascular disease location or other blood vessel conditions
Adherence Superior for Alternative Exercise Modalities in PAD
Completion and adherence rates improved for alternative exercise versus traditional walking
Study Looks at Risk for Bleeding in Percutaneous Tx of PAD
Major bleeding in lower-extremity peripheral vascular interventions tied to higher in-hospital mortality
Hot Water Therapy Aids Patients With Peripheral Arterial Disease
Small study shows it improves functional ability, has potential for cardiovascular conditioning
FDA Issues Update on Mortality Risk With Paclitaxel-Coated Products
Preliminary analyses revealed approximately 50 percent increased risk at five-year follow-up
Paclitaxel Exposure in Vascular Device Not Linked to Mortality
No deaths thought to be related to use of paclitaxel drug-coated balloons for vascular procedures in PAD
Smoking Tied to Peripheral Artery Disease in African-Americans
Current smokers had increased risk for measures of subclinical peripheral artery disease
FDA Investigating Paclitaxel-Coated Balloons, Paclitaxel-Eluting Stents
Investigation triggered by meta-analysis showing possible increased mortality in PAD patients at 2 years
Appropriate Use Criteria Released for Peripheral Artery Intervention
Guideline-directed medical therapy, lifestyle and risk factor modification are cornerstones of therapy
